<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02738411</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC-I/2015/AF-01</org_study_id>
    <nct_id>NCT02738411</nct_id>
  </id_info>
  <brief_title>Influence of Intestinal Microbiota Implantation in Preterm Infants on Microbiota and Immune Orientation at 3 Years</brief_title>
  <acronym>PrimiBiota</acronym>
  <official_title>Influence of Intestinal Microbiota Implantation Parameters in the Neonatal Period in Premature Infants on Microbiota Profiles and Immune Orientation at 3 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this research is to study the links between changes in the intestinal
      microbiota (in terms of diversity) during the first 6 weeks of life for preterm infants and
      the presence / absence of a TH1 immune status at 36 months of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives are to study the links between changes of the intestinal microbiota
      premature infants in terms of:

        -  changing diversity of the microbiota in the first 6 weeks of life;

        -  changes in the bacterial community (UniFrac study) during the first 6 weeks of life;

        -  diversity of the microbiota up to 6 weeks;

      -AND-

        -  diversity of the microbiota at 1, 2 &amp; 3 years;

        -  bacterial communities (UniFrac study) at 1, 2 &amp; 3 years;

        -  lymphocyte subpopulation profiles at 3 years;

        -  serum immunoglobulin A, G, M, E levels at 3 years;

        -  history of infectious episodes, allergic and inflammatory episodes during the first 3
           years of life.

      The links between certain variables known in the literature and neonatal microbiota will be
      confirmed / studied in our population:

        -  mode of delivery;

        -  length (and type) of antibiotic therapy in the neonatal period;

        -  duration of breastfeeding.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 12, 2017</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The presence/absence of a Th1 type immune orientation</measure>
    <time_frame>36 months</time_frame>
    <description>Immune orientation will be determined according to the following ratio determined by lymphocyte stimulation tests: INF-gamma/(INF-gamma+IL+4). The latter ratio varies between 0 and 0.5 with IL-4 &gt; INF-gamma (TH2 orientation) and between 0.5 and 1 when INF-gamma &gt; IL-4 (TH1 orientation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood lymphocyte subset determination</measure>
    <time_frame>36 months</time_frame>
    <description>Subsets are determined according to the presence/absence of the following differentiation clusters: CD3, CD4, CD8, CD19, CD25, CD56, CD127, FOXP3.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Serum Immunoglobulin A level</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Serum Immunoglobulin G level</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Serum Immunoglobulin M level</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Serum Immunoglobulin E level</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The number of days in good health and no medications</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>Day 0 (first meconium)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>Week 1</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>Week 2</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>Week 3</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>Week 4</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>Week 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>Week 6</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>24 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Richness of fecal microbiota (number of operational taxonomic units observed)</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Day 0 (first meconium)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 1</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 2</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 3</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 4</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 6</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>24 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>Day 0 (first meconium)</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>Week 1</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>Week 2</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>Week 3</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>Week 4</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>Week 5</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>Week 6</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>12 months</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>24 months</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional richness of fecal microbiota (number of functional groups observed)</measure>
    <time_frame>36 months</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Day 0 (first meconium)</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 1</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 2</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 3</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 4</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 5</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>Week 6</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>12 months</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>24 months</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional diversity of fecal microbiota (Shannon's index)</measure>
    <time_frame>36 months</time_frame>
    <description>Functional groups are determined via the classification of each OTU according to the following factors: 1) pathogenicity (pathogen/intermediate/commensal); 2) aerobic versus anaerobic; 3) Cocci + versus others.</description>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>Day 0 (first meconium)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>Week 1</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>Week 2</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>Week 3</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>Week 4</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>Week 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>Week 6</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>24 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The relative abundance of primary fecal microbiota families</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>Day 0 (first meconium)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>Week 1</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>Week 2</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>Week 3</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>Week 4</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>Week 5</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>Week 6</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>24 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fecal microbiota unifrac ordination score</measure>
    <time_frame>36 months</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Infant, Premature</condition>
  <arm_group>
    <arm_group_label>The study population</arm_group_label>
    <description>The study population corresponds to infants born at less than 33 weeks of gestation.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be drawn at 36 months for lymphocyte subpopulation characterization,
      stimulation tests and biobanking. Fecal samples at indicated time points will also be banked
      (bacterial rDNA will be extracted).
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of premature babies born at &lt; 33 months gestation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The parents of the patient (or legal guardian if any) have been informed about the
             implementation of the study, its objectives, its constraints, and patient rights

          -  The parents of the patient (or legal guardian if any) must have given their free and
             informed consent and signed the consent form

          -  The patient must be affiliated with or beneficiary of a health insurance plan

          -  Premature infants born at less than 33 weeks of gestation

        Exclusion Criteria:

          -  The patient is participating in another interventional study

          -  It is not possible to correctly inform the parent (or legal guardian, if applicable)

          -  A serious deformity or digestive malformation was diagnosed at birth

          -  During the hospital stay in the neonatology department, the patient had a digestive
             disease requiring surgery (except necrotizing enterocolitis)

          -  A transfer to another hospital is foreseen/predictable (eg, due to geographical
             distance)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Day</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Filleron, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Filleron, MD, PhD</last_name>
    <phone>+33.(0)4.66.68.32.84</phone>
    <email>anne.filleron@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carey M Suehs, PhD</last_name>
    <phone>+33.(0)4.66.68.67.88</phone>
    <email>carey.suehs@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Montpellier - Hôpital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gilles Cambonie, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anne Filleron, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tu-Anh Tran, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine Dunyach-Remy, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Corbeau, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Réseau GRANDIR EN LANGUEDOC-ROUSILLON</name>
      <address>
        <city>Saint Gely Du Fesc</city>
        <zip>34980</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2016</study_first_submitted>
  <study_first_submitted_qc>April 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2016</study_first_posted>
  <last_update_submitted>June 15, 2017</last_update_submitted>
  <last_update_submitted_qc>June 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

